{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:08:47Z","timestamp":1793657327332,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cmi.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T21:09:13Z","timestamp":1675976953000},"page":"744-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis"],"prefix":"10.1016","volume":"29","author":[{"given":"Itziar","family":"Diego-Yag\u00fce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mora-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"V\u00e1zquez-Comendador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Santamarina-Alcantud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"M\u00fa\u00f1ez-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Guti\u00e9rrez-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sanchez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Moreno-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ramos-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Calder\u00f3n-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.02.001_bib1","doi-asserted-by":"crossref","first-page":"625.e1","DOI":"10.1016\/j.eimc.2015.03.015","article-title":"Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)","volume":"33","author":"Gudiol","year":"2015","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"key":"10.1016\/j.cmi.2023.02.001_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2023.02.001_bib3","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cid\/ciy1144","article-title":"Clinical practice variation among adult infectious disease physicians in the management of Staphylococcus aureus bacteremia","volume":"69","author":"Liu","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijantimicag.2017.12.010","article-title":"Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey","volume":"51","author":"Diallo","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2023.02.001_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamainternmed.2018.6226","article-title":"Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with Enterobacteriaceae bacteremia","volume":"179","author":"Tamma","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2023.02.001_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2016.07.013","article-title":"Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections","volume":"48","author":"Kutob","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2023.02.001_bib8","first-page":"5057","article-title":"Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients","volume":"29","author":"Tossey","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cmi.2023.02.001_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106451","article-title":"Antibacterial Resistance Leadership Group (ARLG). Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections","volume":"58","author":"Thaden","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2023.02.001_bib10","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/cid\/ciw828","article-title":"Gram-positive bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group","volume":"64","author":"Doernberg","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib11","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cmi.2023.02.001_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cmi.2016.10.023","article-title":"Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition","volume":"23","author":"Harris","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.02.001_bib13","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.cmi.2023.02.001_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ejcts\/ezy167","article-title":"Statistical primer: propensity score matching and its alternatives","volume":"53","author":"Benedetto","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cmi.2023.02.001_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A\u00a0randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/ciy916","article-title":"Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study","volume":"69","author":"Willekens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib17","doi-asserted-by":"crossref","first-page":"e02345","DOI":"10.1128\/AAC.02345-19","article-title":"Efficacy of early oral switch with \u03b2-lactams for low-risk Staphylococcus aureus bacteremia","volume":"64","author":"Bupha-Intr","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.02.001_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijid.2020.10.097","article-title":"The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia","volume":"102","author":"P\u00e9rez-Rodr\u00edguez","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18773\/austprescr.2020.008","article-title":"Oral or intravenous antibiotics?","volume":"43","author":"McCarthy","year":"2020","journal-title":"Aust Prescr"},{"key":"10.1016\/j.cmi.2023.02.001_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0976-500X.130042","article-title":"Switch over from intravenous to oral therapy: a concise overview","volume":"5","author":"Cyriac","year":"2014","journal-title":"J\u00a0Pharmacol Pharmacother"},{"key":"10.1016\/j.cmi.2023.02.001_bib21","doi-asserted-by":"crossref","first-page":"ofaa151","DOI":"10.1093\/ofid\/ofaa151","article-title":"A narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: Yay or nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmi.2019.05.012","article-title":"Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections","volume":"26","author":"Al-Hasan","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.02.001_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13063-015-0973-x","article-title":"for the SABATO trial group (with linked authorship to the individuals in the Acknowledgements section). Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial","volume":"16","author":"Kaasch","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2023.02.001_bib24","doi-asserted-by":"crossref","first-page":"e00317","DOI":"10.1128\/AAC.00317-20","article-title":"Early oral antibiotic switch for Staphylococcus aureus bacteremia: many are called, but few are chosen","volume":"64","author":"Holland","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.02.001_bib25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2023.02.001_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20166","article-title":"Oral \u03b2-lactam antibiotics vs fluoroquinolones or trimethoprim-sulfamethoxazole for definitive treatment of Enterobacterales bacteremia from a urine source","volume":"3","author":"Sutton","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2023.02.001_bib27","article-title":"Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysis","author":"Mponponsuo","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.02.001_bib28","doi-asserted-by":"crossref","first-page":"1026.e7","DOI":"10.1016\/j.cmi.2022.03.025","article-title":"Complicated and uncomplicated S.\u00a0aureus bacteraemia: an international Delphi survey among infectious diseases experts on definitions and treatment","volume":"28","author":"Hagel","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.02.001_bib29","doi-asserted-by":"crossref","first-page":"106329","DOI":"10.1016\/j.ijantimicag.2021.106329","article-title":"Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"57","author":"Yeager","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2023.02.001_bib30","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/jcm11061502","article-title":"Unreliability of clinical prediction rules to exclude without echocardiography infective endocarditis in Staphylococcus aureus bacteremia","volume":"11","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cmi.2023.02.001_bib31","doi-asserted-by":"crossref","first-page":"ofab642","DOI":"10.1093\/ofid\/ofab642","article-title":"Clinical significance of Staphylococcus aureus in a single positive blood culture bottle","volume":"9","author":"Go","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.02.001_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia","volume":"57","author":"Lopez-Cortes","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2300054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2300054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:33:09Z","timestamp":1761118389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2300054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1198743X2300054X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.02.001","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}